These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15989686)

  • 1. Endpoints in clinical trials on transfusion requirements: the need for a structured approach.
    Hardy JF
    Transfusion; 2005 Jul; 45(1 Suppl):9S-13S. PubMed ID: 15989686
    [No Abstract]   [Full Text] [Related]  

  • 2. Choosing the optimal endpoint(s) for a clinical trial on transfusion.
    Hardy JF; Weiskopf RB
    Transfusion; 2005 Jul; 45(1 Suppl):1S. PubMed ID: 15989683
    [No Abstract]   [Full Text] [Related]  

  • 3. A combined superiority and non-inferiority approach to multiple endpoints in clinical trials.
    Bloch DA; Lai TL; Su Z; Tubert-Bitter P
    Stat Med; 2007 Mar; 26(6):1193-207. PubMed ID: 16791905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endpoints in clinical trials of fluid resuscitation of patients with traumatic injuries.
    Wade CE; Holcomb JB
    Transfusion; 2005 Jul; 45(1 Suppl):4S-8S. PubMed ID: 15989685
    [No Abstract]   [Full Text] [Related]  

  • 5. Some issues with composite endpoints in clinical trials.
    Chi GY
    Fundam Clin Pharmacol; 2005 Dec; 19(6):609-19. PubMed ID: 16313272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
    Glynne-Jones R; Mawdsley S; Novell JR
    Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Design and endpoints of clinical trials in hepatocellular carcinoma.
    Di Maio M; Daniele B; Gallo C; Perrone F
    J Natl Cancer Inst; 2008 Nov; 100(21):1557; author reply 1557-8. PubMed ID: 18957679
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 10. Statistical methods in clinical trials.
    Gebski VJ; Keech AC
    Med J Aust; 2003 Feb; 178(4):182-4. PubMed ID: 12580749
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Clinical endpoints in peripheral endovascular revascularisation trials: a case for standardized definitions.
    Golledge J; Leicht A; Crowther R; Askew C; Gibbs H; Walker PJ
    Eur J Vasc Endovasc Surg; 2009 Apr; 37(4):497; author reply 497-8. PubMed ID: 19213579
    [No Abstract]   [Full Text] [Related]  

  • 12. Endpoints in clinical trials involving hemostasis and bleeding in patients with hemophilia.
    Escobar MA
    Transfusion; 2005 Jul; 45(1 Suppl):2S-3S. PubMed ID: 15989684
    [No Abstract]   [Full Text] [Related]  

  • 13. How to deal with multiple endpoints in clinical trials.
    Neuhäuser M
    Fundam Clin Pharmacol; 2006 Dec; 20(6):515-23. PubMed ID: 17109645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dealing with multiple endpoints.
    Dueck A; Novotny PJ
    Curr Probl Cancer; 2006; 30(6):298-306. PubMed ID: 17123881
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection.
    Jarnagin WR; Gonen M; Maithel SK; Fong Y; D'Angelica MI; Dematteo RP; Grant F; Wuest D; Kundu K; Blumgart LH; Fischer M
    Ann Surg; 2008 Sep; 248(3):360-9. PubMed ID: 18791356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline.
    ; Ferraris VA; Ferraris SP; Saha SP; Hessel EA; Haan CK; Royston BD; Bridges CR; Higgins RS; Despotis G; Brown JR; ; Spiess BD; Shore-Lesserson L; Stafford-Smith M; Mazer CD; Bennett-Guerrero E; Hill SE; Body S
    Ann Thorac Surg; 2007 May; 83(5 Suppl):S27-86. PubMed ID: 17462454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endpoints for assessing drug activity in clinical trials.
    Pazdur R
    Oncologist; 2008; 13 Suppl 2():19-21. PubMed ID: 18434634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of intraoperative normovolemic hemodilution on transfusion requirements for 68 patients undergoing lumbar laminectomies with instrumented posterolateral fusion.
    Epstein NE; Peller A; Korsh J; DeCrosta D; Boutros A; Schmigelski C; Greco J
    Spine (Phila Pa 1976); 2006 Sep; 31(19):2227-30; discussion 2231. PubMed ID: 16946658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Composite endpoints].
    Junod AF
    Rev Med Suisse; 2007 May; 3(111):1272. PubMed ID: 17585633
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating co-primary endpoints collectively in clinical trials.
    Li QH
    Biom J; 2009 Feb; 51(1):137-45. PubMed ID: 19219905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.